Financial implications of sarcopenia in colorectal cancer surgery: a cost analysis in an Australian public hospital
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.19230 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Luke Traeger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Sarcopenia, Colorectal Neoplasms, Hospitals, Public, Costs and Cost Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Adelaide (Research Training Program Stipend), Royal Australasian College of Surgeons (RP Jepson).
Abstract (Originalsprache)
Introduction
Sarcopenia has a detrimental impact on patient outcomes following colorectal surgery, increasing financial strain on the healthcare system. Given the absence of specific Australian data, this study aimed to measure the cost of sarcopenia in the context of colorectal surgery in an Australian public hospital.
Methods
A retrospective cost analysis, following CHEERS guidelines, was conducted on major elective colorectal cancer surgical cases at the Royal Adelaide Hospital between 2018 and 2022. The cross‐sectional psoas area was measured through computed tomography (CT) imaging at the level of the third lumbar vertebrae, and sarcopenia was determined using gender‐specific thresholds. Hospital billing data was used to gather costings (AU$).
Results
Out of 271 patients, 57 (21.0%) comprised the sarcopenic group (SG). SG patients were older (74 vs. 69 years, P < 0.001), had a higher American Society of Anaesthesiologists (>II, 71.9% vs. 53.7%, P = 0.014) and a lower median body mass index (24.8 vs. 28.7 kg/m 2 , P < 0.001). The SG exhibited a greater likelihood of complications (84.2 vs. 68.7%, P = 0.020) and prolonged hospital stay by 1 day (median 7 vs. 6 days, P = 0.027). Despite an increased mean total cost of hospital admission, no statistically significant difference was found (AU$37 712 vs. $34 845, P = 0.296). Multivariate analysis revealed hypoalbuminemia, prolonged operative time, postoperative ileus, return to theatre, Clavien‐Dindo grade ≥3 complications, and prolonged stay increased overall cost ( P < 0.05).
Conclusion
Sarcopenia was not associated with a significantly increased cost of colorectal surgery in our institution. Future studies examining the cost‐effectiveness of prehabilitation programmes targeting sarcopenia should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
- College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
ORCID-Profile: Luke Traeger, Sergei Bedrikovetski, Rowan V David, Tarik Sammour
Förderung
- University of Adelaide (Research Training Program Stipend)
- Royal Australasian College of Surgeons (RP Jepson)
Zitieren
APA
Traeger, L., Bedrikovetski, S., David, R. V., Jay, A. A., Moore, J. W., & Sammour, T. (2024). Financial implications of sarcopenia in colorectal cancer surgery: a cost analysis in an Australian public hospital. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19230
Vancouver
Traeger L, Bedrikovetski S, David RV, Jay AA, Moore JW, Sammour T. Financial implications of sarcopenia in colorectal cancer surgery: a cost analysis in an Australian public hospital. ANZ Journal of Surgery. 2024. doi:10.1111/ans.19230
BibTeX
@article{Traeger2024,
author = {Traeger, Luke and Bedrikovetski, Sergei and David, Rowan V and Jay, Alice A and Moore, James W and Sammour, Tarik},
title = {Financial implications of sarcopenia in colorectal cancer surgery: a cost analysis in an Australian public hospital},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.19230}
}
EUVIMED